Copyright
©The Author(s) 2022.
World J Gastrointest Endosc. Jun 16, 2022; 14(6): 354-366
Published online Jun 16, 2022. doi: 10.4253/wjge.v14.i6.354
Published online Jun 16, 2022. doi: 10.4253/wjge.v14.i6.354
Ref. | Study design | Number of patients | Technical success | Clinical success | Adverse events |
Romero-Castro et al[30], 2013 | Retrospective analysis of a prospectively maintained database | 30 total patients, 11 ECA, 19 CYA | 27/30 (90%) | 18/19 (96.7%) CYA; 10/11 (90.9%) ECA | 40% total AEs; CYA 11/19 (57.9%); ECA 1/11 (9.1%) |
Lôbo et al[17], 2019 | Randomized Controlled Trial | 32 total patients; 16 ECA + CYA, 16 CYA | - | - | Early AEs: 8 (50%) ECA + CYA; 10 (62.5%) CYA. Pulmonary embolism: 4 (25%) ECA + CYA; 8 (50%) CYA |
Robles-Medranda et al[29], 2019 | Randomized Controlled Trial | 60 total patients, 30 ECA + CYA; 30 ECA | 60/60 (100%) in both groups | ECA + CYA 30/30 (100%), ECA 27/30 (90%) | ECA + CYA 2/30 (6.7%); ECA 1/30 (3.3%) |
Bazarbashi et al[16], 2020 | Prospective Study | 40 total patients; 10 ECA, 30 CYA | 10/10 (100%) ECA; 29/30 (96.7%) CYA | 10/10 (100%) ECA; 26/30 (87%) CYA | 10% ECA; 20% CYA |
- Citation: Fugazza A, Khalaf K, Colombo M, Carrara S, Spadaccini M, Koleth G, Troncone E, Maselli R, Repici A, Anderloni A. Role of endoscopic ultrasound in vascular interventions: Where are we now? World J Gastrointest Endosc 2022; 14(6): 354-366
- URL: https://www.wjgnet.com/1948-5190/full/v14/i6/354.htm
- DOI: https://dx.doi.org/10.4253/wjge.v14.i6.354